Scientists propose distance-based visual miRNA biosensor

Point-of-care testing (POCT) devices show great advantages over conventional diagnostic tests in being accessible to patients and providing timely diagnostic information. The global POCT market has grown remarkably over the past few decades. Distance-based devices are attracting great interest due to their simplicity, affordability, and ease of application.